Ind-Swift Laboratories Limited has successfully passed four special resolutions through a postal ballot process, with the last date of receipt of postal ballot forms being April 30, 2026. The resolutions, disclosed to the stock exchanges on May 5, 2026, encompassed key leadership restructuring decisions, including the change in designation of a senior director, appointments of two Managing Directors, and approval of remuneration for the Whole-Time Director. All four resolutions were passed with the requisite majority via remote e-voting facilitated by Central Depository Services (India) Limited.

Resolutions Passed

The postal ballot covered four special resolutions, each receiving overwhelming shareholder approval. The following table summarises the resolutions put to vote:

The promoter and promoter group were noted as not interested in any of the four agenda items.

Voting Results Summary

The remote e-voting platform was open from Wednesday, April 01, 2026 (9:00 A.M. IST) to Thursday, April 30, 2026 (5:00 P.M. IST). The record date for determining voting entitlements was Friday, March 27, 2026. As on the record date, the total number of shareholders stood at 39,222. A total of 36,164,227 votes were polled across all four resolutions, representing 41.6463% of the total outstanding shares of 86,836,558.

The detailed voting outcome for each resolution is presented below:

Category-Wise Voting Breakdown

Across all four resolutions, the promoter and promoter group cast 32,210,187 votes via e-voting, representing 86.2751% of their total shareholding of 37,334,278 shares, with 100.0000% of their votes in favour. Public institutional shareholders polled 260,853 votes out of their total holding of 12,054,112 shares (2.1640%), with 83.0686% in favour and 16.9314% against across all resolutions. Public non-institutional shareholders polled 3,693,187 votes from a total holding of 37,448,168 shares (9.8621%), with votes in favour exceeding 99.96% across all resolutions.

Scrutinizer's Report and Process

The postal ballot notice was dated March 27, 2026, and the scrutinizer, CS Vishal Arora (Membership No. 4566, C.P. No. 3645), was appointed by the Board of Directors at its meeting held on March 27, 2026. The scrutinizer's report was issued to the company on May 5, 2026. The e-voting data was downloaded from the CDSL e-voting system in the presence of two independent witnesses, Ms. Anita Bhargav and Mr. Arun Kumar, who are not in the employment of the company. The scrutinizer confirmed that all four resolutions stand passed with the requisite majority under e-voting. The voting results and scrutinizer's report are available on the company's website at www.indswiftgroup.com . The disclosure was signed by Pardeep Verma, VP-Corporate Affairs & Company Secretary, and countersigned by Mr. Mavrattan Munjal, Chairman.

Ind swift laboratories has received a disclosure from HCP Investments regarding the disposal of a significant stake in the pharmaceutical company. The Mauritius-based investor sold 6,503,423 equity shares, representing 7.5% of the total paid-up share capital, through open market transactions.

Transaction Details

The share disposal was executed over a period of five days, with specific timing and volume details outlined in the regulatory filing:

Shareholding Changes

The disposal has significantly altered HCP Investments' position in Ind-Swift Laboratories, with the investor's stake reducing substantially:

Regulatory Compliance

The disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. HCP Investments submitted the required documentation on April 21, 2026, which was subsequently forwarded by Ind-Swift Laboratories to both stock exchanges on April 22, 2026.

The company's total equity share capital stands at 86,711,558 shares, and HCP Investments confirmed it does not belong to the promoter or promoter group category. The transaction was signed off by Mr. Neermalsingh Poonie on behalf of HCP Investments from Mauritius.

Company Information

Ind-Swift Laboratories Limited operates manufacturing facilities in Punjab and Jammu & Kashmir, with its registered office located in Chandigarh. The company maintains Unit I at NH-21, Village Jawaharpur, Tehsil Derabassi, District SAS Nagar (Mohali), Punjab, and Unit II at Phase 1, SIDCO Industrial Growth Centre, Samba, Jammu & Kashmir.